This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Novo Nordisk A/s, Other. Active years: 1991-1993.
Company Filing History:
1 out of 1,801 
1 out of 834,350 Years Active: 1991-1993
Title: Lars Jacob Knudsen: Innovator in Azaheterocyclic Carboxylic Acids
Introduction
Lars Jacob Knudsen is a notable inventor based in Vedbæk, Denmark. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds that have potential pharmaceutical applications. With a total of 2 patents, his work focuses on innovative chemical structures that can impact various therapeutic areas.
Latest Patents
Lars Jacob Knudsen's latest patents include the development of N-substituted azaheterocyclic carboxylic acids. These compounds are characterized by an ether group forming part of the N-substituent, which enhances their efficacy as potent inhibitors of GABA uptake from the synaptic cleft. The general formula for these compounds includes various substituents such as phenyl, thienyl, and pyrrolyl groups, making them versatile in their applications.
Career Highlights
Throughout his career, Lars has worked with prominent companies, including Novo Nordisk A/S. His experience in the pharmaceutical industry has allowed him to collaborate on various projects that aim to advance medical science through innovative chemical solutions.
Collaborations
Lars has had the opportunity to work alongside esteemed colleagues such as Ursula Sonnewald and Anker S. Jorgensen. These collaborations have contributed to the success of his research and the development of his patented inventions.
Conclusion
Lars Jacob Knudsen is a distinguished inventor whose work in azaheterocyclic carboxylic acids showcases his commitment to advancing pharmaceutical science. His innovative contributions continue to have a lasting impact on the field.